Drugplain

Diacomit 250 mg/1

stiripentol · POWDER, FOR SUSPENSION · BIOCODEX, INC.

No Recall History
Plain English

Diacomit (stiripentol) is an oral powder medication used to treat severe myoclonic epilepsy of infancy (SMEI), a rare and serious form of childhood epilepsy. It is typically used along with other anti-seizure medicines to help reduce seizure frequency in affected patients.

Key Facts

Brand Name
Diacomit
Generic Name
stiripentol
NDC Code (Product)
68418-7941
Manufacturer
BIOCODEX, INC.
Strength
250 mg/1
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Marketing Status
Application #
NDA207223
Marketing Start
08/21/2018

Recall History

No Recall History

Frequently Asked Questions

What is Diacomit used for?

Diacomit (stiripentol) is an oral powder medication used to treat severe myoclonic epilepsy of infancy (SMEI), a rare and serious form of childhood epilepsy. It is typically used along with other anti-seizure medicines to help reduce seizure frequency in affected patients.

Is Diacomit a controlled substance?

Diacomit is not classified as a controlled substance by the DEA.

What is the generic name for Diacomit?

The generic name for Diacomit is stiripentol. There are no other listed brand versions of stiripentol.

What is the NDC code for Diacomit 250 mg/1?

The NDC (National Drug Code) for Diacomit 250 mg/1 is 68418-7941, listed by BIOCODEX, INC..

Product NDC

68418-7941

Package NDC

68418-7941-6

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)